Hims & Hers Health stock analysis
Hims & Hers Health (82W) Stock Price & Analysis
82W Stock Chart & Stats
- Day’s Range
- EUR 17.58 - EUR 18.05
- 52-Week Range
- EUR 11.82 - EUR 35.25
- Previous Close
- EUR 18.24
- Volume
- N/A
- Average Volume (3M)
- 2,426
- Market Cap
- EUR 4.20B
- Enterprise Value
- EUR 7.81B
- Total Cash (Recent Filing)
- EUR 712.22M
- Total Debt (Recent Filing)
- EUR 1.56B
- Price to Earnings (P/E)
- ―
- Beta
- 1.37
- Next Earnings
- Mar 01, 2027 (Est.)
- EPS Estimate
- -0.02
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Rapid Revenue Growth
Strong and accelerating revenue growth indicates expanding demand for the company’s digital health platform and treatment categories. Sustained top-line momentum can improve operating leverage, fund product investment, and reinforce Hims & Hers’ position as its customer base and geographic reach expand.
Scale And International Expansion
A large, growing customer base gives the platform meaningful scale across acquisition, care delivery, and fulfillment. Expansion across four continents and continued subscriber growth broaden the addressable market, diversify revenue sources, and create a stronger foundation for recurring consumer relationships.
Cash Generation And Liquidity
Positive free cash flow and substantial cash and investments provide resources to support product development, international expansion, and operational investment without relying solely on external financing. This liquidity also gives management greater flexibility while the business scales into new specialties and markets.
Bears Say
Elevated Leverage
The sharp increase in leverage and smaller equity cushion raise financial risk as the company continues investing and navigating earnings volatility. A more aggressive capital structure can restrict strategic flexibility, increase financing sensitivity, and make weaker operating periods more difficult to absorb.
Profitability And Margin Pressure
The return to a GAAP loss, alongside lower gross margins, shows that rapid growth is not currently translating consistently into bottom-line profitability. Margin pressure from branded weight loss products and international expansion could limit earnings conversion and make future results more dependent on execution.
Subscriber Growth Headwinds
Sequential subscriber contraction creates a near-term risk to the recurring-revenue model, particularly if reduced marketing investment continues to slow customer additions. Although the annual subscriber base is growing, sustained acquisition or retention pressure could weaken growth efficiency and delay operating leverage.
82W FAQ
What was Hims & Hers Health’s price range in the past 12 months?
What is Hims & Hers Health’s market cap?
When is Hims & Hers Health’s upcoming earnings report date?
How were Hims & Hers Health’s earnings last quarter?
Is Hims & Hers Health overvalued?
Does Hims & Hers Health pay dividends?
What is Hims & Hers Health’s EPS estimate?
How many shares outstanding does Hims & Hers Health have?
What happened to Hims & Hers Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Hims & Hers Health?
What is the TipRanks Smart Score and how is it calculated?
Hims & Hers Health Stock Smart Score
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Andrew Dudum
- Employees
- 2,442
- Website
- www.hims.com
- Address
- 2269 Chestnut Street, San Francisco, CA, 94123, US
Hims & Hers Health (82W) Earnings & Revenues
82W Company Deck
82W Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, with strong 49% year-over-year revenue growth, accelerating domestic performance, rapidly expanding international revenue, positive free cash flow, growing adjusted EBITDA, new partnerships and specialty launches, and substantial progress in AI-enabled care. The main negatives were the sequential subscriber decline, $33 million GAAP net loss, 7-percentage-point sequential gross-margin decline, revenue deferrals, lowered adjusted EBITDA guidance, and expected near-term subscriber and margin volatility. Management characterized these pressures as deliberate investments and timing effects while maintaining expectations for positive free cash flow and long-term growth.
View all DE:82W earnings summaries82W Net sales Breakdown
- 96.60% Online
- 3.40% Wholesale
82W Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |












